下一代诊断全球市场展望(2023 年)
市场调查报告书
商品编码
1257362

下一代诊断全球市场展望(2023 年)

Global Next generation Diagnostics, Outlook 2023

出版日期: | 出版商: Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

本报告研究和分析了全球下一代诊断市场,提供了每个地区的市场趋势和增长预测以及未来增长机会等信息。

内容

战略要务

  • 为什么越来越难成长?
  • 战略要务 8 (TM)
  • 三大战略要务对下一代诊断行业的影响
  • 增长机会推动增长管道引擎 (TM)

成长环境

  • 市场细分
  • 成长环境

宏观经济因素

  • 5 大全球经济亮点(2022 年)
  • 5 大全球经济亮点(2023 年)
  • 全球 GDP 增长预测
  • 主要经济体的衰退/放缓预测
  • 全球 GDP 增长概况
  • 发达经济预测 (2023)
  • 新兴市场预测 (2023)
  • 区域风险和政策方向 (2023)
  • 供应链中断 - 影响分析
  • 经济不确定性 - 影响分析

收入趋势 - 2023

  • 下一代诊断市场工作流程
  • 收入预测:按部门分类
  • IVD创新技术的影响与应用
  • 竞争环境
  • 收益分成
  • 收益分成分析
  • 竞争矩阵

併购

  • 着名的併购(2022 年)
  • 併购 - 历史分析

6 大预测 - 2023

  • 预测 1:人员短缺将推动 2023 年实验室自动化实现两位数增长
  • 预测 2:25% 的综合症组检测增长来自传染病部分
  • 预测 3:通过监管变革增加证据生成潜力支持转型的数字病理学集
  • 预测 4:预计临床实验室服务将在美国和欧盟市场继续受到整合活动
  • 预测 5:肿瘤检测在因 COVID-19 大流行而受到抑制两年后重拾势头
  • 预测 6:实验室预算将保持不变。 成本压力可能会延迟实验室经理投资新设备

细分市场展望 - 2023

  • 市场概况 (2023)

临床化学与免疫分析 - 2023

  • 临床化学和免疫分析市场概况
  • 临床化学和免疫测定市场 - 值得关注的公司

分子诊断学 - 2023

  • 分子诊断市场概况
  • 分子诊断市场 - 值得关注的公司

床旁检测 - 2023

  • POCT 市场概况
  • POCT 市场 - 值得关注的公司
  • 收入预测:按地区
  • 收入预测:按地区
  • 收入预测分析 - 下一代诊断市场:按地区

成长机会

  • 增长机会 1:用于精准肿瘤学的液体活检
  • 增长机会 2:人工智能在分子诊断中的整合
  • 增长机会 3:互联实验室、智能实验室
  • 增长机会 4:传染病的分散式 POCT
  • 增长机会 5:中东和非洲的基因组学

结论

下一步

简介目录
Product Code: K8A0-55

Automation and Digitization Drive the Next Growth Phase Post-COVID-19

As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on structural solutions that enhance healthcare delivery for sustainable growth. That is why automation and robotization solutions for tasks and processes are important. Besides digital solutions that allow physicians to remotely monitor and connect with patients, they should also facilitate real-time digital responses.

The study examines next-generation diagnostics market trends and growth projections to 2028 across different geographical regions, innovative in vitro diagnostics technologies and applications, major vendors to watch, and growth opportunities in the post-pandemic future.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Next-generation Diagnostics Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Environment

  • Market Segmentation
  • Growth Environment

Macroeconomic Factors

  • Top 5 Global Economic Highlights of 2022
  • Top 5 Global Economic Highlights of 2023
  • Global GDP Growth Expectations
  • Recessionary/Slowdown Expectations for Major Economies
  • Global GDP Growth Snapshot
  • Advanced Economy Predictions for 2023
  • Emerging Market Economy Predictions for 2023
  • 2023 Regional Risks and Policy Direction
  • Supply Chain Disruptions-Impact Analysis
  • Economic Uncertainties-Impact Analysis

Revenue Trends-2023

  • Next-generation Diagnostics Market Workflow
  • Revenue Forecast by Segment
  • Revenue Forecast by Segment (continued)
  • Impact and Applications of Innovative Technologies in IVD
  • Competitive Environment
  • Revenue Share
  • Revenue Share Analysis
  • Competitor Matrix
  • Competitor Matrix (continued)

Mergers and Acquisitions

  • Notable Mergers and Acquisitions in 2022
  • M&A-Historical Analytics

Top 6 Predictions-2023

  • Prediction 1: Staff Shortages to Push Double-digit Laboratory Automation Growth Rate in 2023
  • Prediction 2: 25% of the Total Growth in Syndromic Panel Testing to Come from the Infectious Disease Segment
  • Prediction 3: Digital Pathology Set for Transformation Supported by Better Evidence-generation Possibilities Due to Regulatory Changes
  • Prediction 4: Clinical Lab Services are Expected to Undergo Continuous Consolidation Activities in the US and EU Markets
  • Prediction 5: Oncology Testing to Regain Traction After Being Subdued for 2 Years Owing to the COVID-19 Pandemic
  • Prediction 6: Lab Budgets to Remain Flat; Lab Managers may Look to Delay Capex on New Instruments/Equipment Due to Cost Pressures

Segment Outlook-2023

  • 2023 Market Snapshot

Clinical Chemistry and Immunoassays-2023

  • Clinical Chemistry and Immunoassays Market Snapshot
  • Clinical Chemistry and Immunoassays Market-Companies to Watch

Molecular Diagnostics-2023

  • Molecular Diagnostics Market Snapshot
  • Molecular Diagnostics Market-Companies to Watch

Point-of-care Testing-2023

  • POCT Market Snapshot
  • POCT Market-Companies to Watch
  • Revenue Forecast by Region
  • Percent Revenue Forecast by Region
  • Revenue Forecast Analysis by Region-Next-generation Diagnostics Market

Growth Opportunity Universe

  • Growth Opportunity 1: Liquid Biopsy for Precision Oncology
  • Growth Opportunity 1: Liquid Biopsy for Precision Oncology (continued)
  • Growth Opportunity 2: Integration of AI in Molecular Diagnostics
  • Growth Opportunity 2: Integration of AI in Molecular Diagnostics (continued)
  • Growth Opportunity 3: Connected and Smart Labs
  • Growth Opportunity 3: Connected and Smart Labs (continued)
  • Growth Opportunity 4: Decentralized POCT for Infectious Diseases
  • Growth Opportunity 4: Decentralized POCT for Infectious Diseases (continued)
  • Growth Opportunity 5: Genomics in the Middle East and Africa
  • Growth Opportunity 5: Genomics in the Middle East (continued)

Conclusions

  • Conclusions and Future Outlook
  • Future of Diagnostics

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer